Clinical Trials
Source: CCM
- Score: 2
Sickle Cell Study
- Score: 1
Sickle Cell Study
- Score: 0Sickle Cell Disorders
A Phase 1/2 Study to Evaluate the Safety and Efficacy of a Single Dose of Autologous Clustered Regularly Interspaced Short Palindromic Repeats Gene-edited CD34+ Human Hematopoietic Stem and Progenitor Cells (EDIT-301) in Subjects With Severe Sickle Cell Disease